These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9769892)

  • 1. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.
    Mereghetti L; Marquet-van der Mee N; Loulergue J; Rolland JC; Audurier A
    Pathol Biol (Paris); 1998 May; 46(5):319-24. PubMed ID: 9769892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.
    Hafiane A; Ravaoarinoro M
    Pathol Biol (Paris); 2011 Oct; 59(5):e109-14. PubMed ID: 19896303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
    Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
    Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE
    J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
    Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
    Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India.
    Agarwal G; Kapil A; Kabra SK; Chandra R; Das B; Diwedi SN
    Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudomonas aeruginosa infection in cystic fibrosis: predominance of a single strain and the influence of antibiotic therapy and the environment].
    Michel-Briand Y; Plesiat P; Godard C; Noir A; Estavoyer JM
    Bull Acad Natl Med; 1992 Nov; 176(8):1159-69; discussion 1170-1. PubMed ID: 1300222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital.
    Bradbury RS; Champion AC; Reid DW
    J Hosp Infect; 2009 Oct; 73(2):151-6. PubMed ID: 19699556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients.
    Schelstraete P; Deschaght P; Van Simaey L; Van Daele S; Haerynck F; Vaneechoutte M; De Baets F
    J Cyst Fibros; 2010 Mar; 9(2):99-103. PubMed ID: 20004150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Giordano A; Magni A; Graziani C; Sessa R; Quattrucci S; Cipriani P
    New Microbiol; 2001 Apr; 24(2):157-63. PubMed ID: 11346299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenotypic and genotypic (randomly amplified polymorphic DNA analysis and multiple-locus variable-number tandem-repeat analysis) charaterization of 96 clinical isolates of Pseudomonas aeruginosa in the F. Bourguiba hospital (Monastir, Tunisia)].
    Ben Haj Khalifa A; Vu-Thien H; Pourcel C; Khedher M; Mastouri M; Moissenet D
    Pathol Biol (Paris); 2010 Feb; 58(1):84-8. PubMed ID: 19892484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common RAPD pattern of Pseudomonas aeruginosa from patients and tap water in a medical intensive care unit.
    Trautmann M; Bauer C; Schumann C; Hahn P; Höher M; Haller M; Lepper PM
    Int J Hyg Environ Health; 2006 Jul; 209(4):325-31. PubMed ID: 16740415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Aaron SD; Kottachchi D; Ferris WJ; Vandemheen KL; St Denis ML; Plouffe A; Doucette SP; Saginur R; Chan FT; Ramotar K
    Eur Respir J; 2004 Oct; 24(4):631-7. PubMed ID: 15459143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp--a molecular-epidemiological study.
    Hunfeld KP; Schmidt C; Krackhardt B; Posselt HG; Bargon J; Yahaf Y; Schäfer V; Brade V; Wichelhaus TA
    Wien Klin Wochenschr; 2000 Apr; 112(7):329-33. PubMed ID: 10849957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
    Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
    Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.